Safecor Health
Safecor Health (United States) has no DMF, CEP or site registration linked in our records. 50 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Safecor Health: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/safecor-health
Overview
Safecor Health is a pharmaceutical company headquartered in Columbus, United States.
FDA compliance signals
50 FDA enforcement records linked to this company.
- recall — Class II2026-11-04
Manufacturer is recalling batches due to co-mingled tablet.
- recall — Class II2026-09-23
Failed Stability Specifications
- recall — Class II2026-09-23
Failed Stability Specifications
- recall — Class II2026-09-23
Failed Stability Specifications
- recall — Class II2026-09-23
Failed Stability Specifications
- recall — Class II2026-09-23
Failed Stability Specifications
- recall — Class II2026-09-23
Failed Stability Specifications
- 4832026-06-12
Investigations of discrepancies, failures
- 4832026-06-12
Prepared for each batch, include complete information
- recall — Class II2026-05-27
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
- recall — Class II2026-05-27
Presence of a Foreign Substance; black particles observed in liquid
- recall — Class II2025-12-10
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
- 4832025-10-28
Procedures not in writing, fully followed
- recall — Class II2025-03-12
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
- recall — Class II2025-03-12
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
- recall — Class II2025-03-12
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
- recall — Class II2025-03-12
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
- recall — Class II2025-03-12
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
- recall — Class II2024-11-27
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- recall — Class II2024-11-27
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- recall — Class II2024-11-27
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- recall — Class II2024-11-27
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- recall — Class II2024-11-27
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- 4832024-06-24
Equipment Design, Size and Location
- 4832024-06-24
Complaint Handling Procedure
- 4832024-06-24
Items to cover on annual reviews
- recall — Class II2023-11-08
CGMP Deviations: Recall due to the absence of USP CGMP compendial requirements.
- warning_letter2023-09-05
FDA Warning Letter (drug product)
- 4832023-09-01
Written records kept in individual logs
- 4832023-09-01
Absence of Written Procedures
- 4832023-09-01
Changes to Procedures Not Reviewed, Approved
- 4832023-09-01
Identity Testing of Each Component
- 4832023-09-01
Reprocessing/quality control unit
- 4832023-09-01
Sample size - test intervals
- 4832023-09-01
Investigations of discrepancies, failures
- 4832023-03-16
Investigations of discrepancies, failures
- 4832023-03-16
Packaging line inspection before use
- 4832023-03-16
Cleaning / Sanitizing / Maintenance
- 4832023-03-16
Complaint Investigation/Follow-Up Findings
- 4832023-03-16
Master production and control records, procedure
- 4832023-03-16
Establish reliability of supplier's C of A
- 4832018-02-02
Buildings of Suitable Size, Construction, Location
- 4832018-02-02
Procedures not in writing, fully followed
- 4832018-02-02
Protective Apparel Not Worn
- 4832017-10-19
Review of representative number of batches
- 4832017-10-19
Establish reliability of supplier's C of A
- 4832017-10-19
Reporting of adverse drug experience to FDA
- 4832017-10-19
Procedures not in writing, fully followed
- 4832017-10-19
Changes to Procedures Not Reviewed, Approved
- 4832017-10-19
Equipment for Environmental Control
Is this Safecor Health?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.